ASD-NP6 is a novel formulation of intestinally absorbed oral alpha-cyclodextrin as a unique 'intermittent fasting mimetic' (CoM pat. pend) to promote healthy aging
- Maintaining lysosomal function
- Restoring autophaging,
(ie, reducing garbaging) and
- Reducing inflammaging.
The MoA of ASD-NP6 was proven to improve age-related functions in several in-vivo and clinical studies.